Elevation Oncology, the biotech startup focused on the development of precision medicines for patients with genomically defined cancers, has raised $65M in Series B funding from investors that include Vivo Capital, Cormorant Asset Management, Aisling Capital, venBio Partners, Boxer Capital, Samsara BioCapital, Janus Henderson Investors, Vertex Ventures HC, BVF Partners, Qiming Venture Partners USA, and Driehaus Capital Management. Founded by Shawn M. Leland in 2019, Elevation Oncology has now raised a total of $97.5M in reported equity funding.
The AlleyWatch audience is driving progress and innovation on a global scale. With its regional media properties, AlleyWatch serves as the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including having prominent brand placement in a high-visibility piece like this, which will be read by the vast majority of key influencers in the New York business community and beyond. Find out more here.